Asia Pacific Low Molecular Weight Heparin Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application [Deep Vein Thrombosis, Acute Coronary Syndrome (ACS), Pulmonary Embolism, and Others], and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 146    |    Report Code: TIPRE00027131    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Low Molecular Weight Heparin Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Low Molecular Weight Heparin Market – By Product Type

1.3.2        APAC Low Molecular Weight Heparin Market – By Packaging

1.3.3        APAC Low Molecular Weight Heparin Market – By Application

1.3.4        APAC Low Molecular Weight Heparin Market – By End User

1.3.5        APAC Low Molecular Weight Heparin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Low Molecular Weight Heparin Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Low Molecular Weight Heparin Market– Key Market Dynamics

5.1         Market Drivers

5.2         Market Restraints

5.3         Future Trends

5.4         Impact Analysis

6.           Low Molecular Weight Heparin Market– APAC Analysis

6.1         APAC Low Molecular Weight Heparin Market Revenue Forecast and Analysis

7.           APAC Low Molecular Weight Heparin Market– By Product Type

7.1         Overview

7.2         APAC Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

7.3         Enoxaparin

7.3.1        Overview

7.3.2        Enoxaparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.4         Dalteparin

7.4.1        Overview

7.4.2        Dalteparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.5         Nadroparin

7.5.1        Overview

7.5.2        Nadroparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.6         Fraxiparine

7.6.1        Overview

7.6.2        Fraxiparine: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.7         Tinzaparin

7.7.1        Overview

7.7.2        Tinzaparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8.           APAC Low Molecular Weight Heparin Market– By Packaging

8.1         Overview

8.2         APAC Low Molecular Weight Heparin Market Share by Packaging - 2021 & 2028 (%)

8.3         Multi-Vials

8.3.1        Overview

8.3.2        Multi-Vials: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8.4         Prefilled Syringes

8.4.1        Overview

8.4.2        Prefilled Syringes: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Low Molecular Weight Heparin Market– By Application

9.1         Overview

9.2         APAC Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

9.3         Deep Vein Thrombosis

9.3.1        Overview

9.3.2        Deep Vein Thrombosis: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.4         Acute Coronary Syndrome (ACS)

9.4.1        Overview

9.4.2        Acute Coronary Syndrome (ACS): APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.5         Pulmonary Embolism

9.5.1        Overview

9.5.2        Pulmonary Embolism: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.        APAC Low Molecular Weight Heparin Market– By End User

10.1      Overview

10.2      APAC Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.5      Ambulatory Surgical Centers

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

11.        APAC Low Molecular Weight Heparin Market – Country Analysis

11.1      APAC: Low Molecular Weight Heparin Market

11.1.1     Overview

11.1.2     APAC: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)

11.1.2.1       China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       China: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)

11.1.2.1.3       China: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.1.4       China: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.1.5       China: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

11.1.2.2       Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Japan: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)

11.1.2.2.3       Japan: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.2.4       Japan: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.2.5       Japan: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

11.1.2.3       India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       India: Low Molecular Weight Heparin Market, By Product Type, 2019–2028 (USD Million)

11.1.2.3.3       India: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.3.4       India: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.3.5       India: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

11.1.2.4       Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.1       Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.2       Australia: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)

11.1.2.4.3       Australia: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.4.4       Australia: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.4.5       Australia: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

11.1.2.5       South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.1       South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.2       South Korea: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)

11.1.2.5.3       South Korea: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.5.4       South Korea: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.5.5       South Korea: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

11.1.2.6       Rest of APAC: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.1       Rest of APAC: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.2       Rest of APAC: Low Molecular Weight Heparin Market, By Product type, 2019–2028 (USD Million)

11.1.2.6.3       Rest of APAC: Low Molecular Weight Heparin Market, By Packaging, 2019–2028 (USD Million)

11.1.2.6.4       Rest of APAC: Low Molecular Weight Heparin Market, By Application, 2019–2028 (USD Million)

11.1.2.6.5       Rest of APAC: Low Molecular Weight Heparin Market, by End User, 2019–2028 (USD Million)

12.        Impact of COVID-19 Pandemic on APAC Low Molecular Weight Heparin Market

12.1      APAC: Impact Assessment of COVID-19 Pandemic

13.        APAC Low Molecular Weight Heparin Market–Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.        Company Profiles

14.1      TEVA PHARMACEUTICAL INDUSTRIES LTD

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Abbott

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Novartis

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Sanofi

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Pfizer Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      B. Braun Medical Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Dr. Reddy's Laboratories

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      LEO Pharma A/S

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Aspen Holdings

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Changzhou Qianhong Biopharma Co Ltd

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             APAC Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan: Low Molecular Weight Heparin Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan: Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Low Molecular Weight Heparin Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 11.          India: Low Molecular Weight Heparin Market, By Packaging– Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Low Molecular Weight Heparin Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 13.          India: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of APAC: Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of APAC: Low Molecular Weight Heparin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments in the APAC Low Molecular Weight Heparin Market

Table 27.          Inorganic Developments in the APAC Low Molecular Weight Heparin Market

Table 28.          Glossary of Terms, APAC Low Molecular Wight Heparin Market

 


LIST OF FIGURES

Figure 1.           APAC Low Molecular Weight Heparin Market Segmentation

Figure 2.           APAC Low Molecular Weight Heparin Market, By Country

Figure 3.           APAC Low Molecular Weight Heparin Market Overview

Figure 4.           Enoxaparin Segment Held Largest Share of Product Type Segment in APAC Low Molecular Weight Heparin Market

Figure 5.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           APAC Low Molecular Weight Heparin Market Impact Analysis of Driver and Restraints

Figure 9.           APAC Low Molecular Weight Heparin Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        APAC Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

Figure 11.        Enoxaparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Dalteparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Nadroparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Fraxiparine: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Tinzaparin: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC LMWH Market Share by Packaging - 2021 & 2028 (%)

Figure 18.        Multi-Vials: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Prefilled Syringes: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        APAC Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

Figure 21.        Deep Vein Thrombosis: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Acute Coronary Syndrome (ACS): APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Pulmonary Embolism: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

Figure 26.        Hospitals: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Clinics: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Ambulatory Surgical Centers: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Others: APAC Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        APAC: Low Molecular Weight Heparin Market, by Key Country – Revenue (2021) (USD Million)

Figure 31.        APAC: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)

Figure 32.        China: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Japan: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        India: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Australia: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        South Korea: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Rest of APAC: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

The List of Companies - Asia Pacific Low Molecular Weight Heparin Market

  1. Abbott
  2. Aspen Holdings
  3. B. Braun Medical Inc.
  4. Changzhou Qianhong Biopharma Co Ltd
  5. Dr. Reddy's Laboratories
  6. LEO Pharma A/S
  7. Novartis
  8. Pfizer Inc.
  9. Sanofi
  10. TEVA PHARMACEUTICAL INDUSTRIES LTD